5:51 AM
 | 
Jan 29, 2019
 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Staphylococcus

In vitro, cell culture and mouse studies identified three TNC-based fusion proteins against S. aureus leukocidin ED or S. aureus γ-hemolysin AB that could help prevent and treat Staphylococcus infections. Screening of libraries of centyrins, which are protein scaffolds derived from the FN3 consensus-binding sequence of human TNC, against S. aureus leukocidins in binding and human neutrophil-based activity assays yielded...

Read the full 285 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >